All Articles

A new Sunnyvale service claims it can turn AI hardware concepts into investor-ready demos in just 21 days, attacking the notorious development bottleneck.

Signal's encryption is world-class, but it can't stop human error. A new layer of 'data-centric' security aims to protect sensitive data after it's stolen.

A landmark U.S. collaboration between Heron Power and LG aims to solve the energy crisis sparked by AI, pairing next-gen transformers with domestic batteries.

The refrigerated section is no longer just for basics. It's a hub for innovation where protein, convenience, and global flavors are reshaping our diets.

NexTel Medical acquires two telehealth firms for an instant $135K in monthly revenue, aiming to launch its Maxasome™ exosome therapies to 1,850 clinics.

Static PDFs and fragmented sales pitches are failing. A new class of AI-guided platforms is helping buyers build trust on their own terms. What does this mean?

With FDA clearance for its MagSense® trial, Imagion Biosystems' molecular MRI could change how we see cancer, offering a non-radioactive, high-precision future.

AM Best's negative outlook for a Pennsylvania insurer reveals a deeper crisis. A 16.5% surplus loss from weather is a harbinger for the entire sector.

As Vallarta Supermarkets expands to Merced, it reveals a masterclass in durable growth: a strategy built not on price wars, but on deep community integration.

Trillium's sale of its nuclear valve unit to Framatome isn't just a divestment; it's a strategic realignment reshaping the critical infrastructure landscape.

Keysight's new RF signal analyzers promise to slash development time for 5G and beyond. But are they the definitive answer to the complexity crisis facing engineers?

EA SPORTS unveils its College Football 27 cover stars, leveraging the NIL era to fuse authenticity with a powerful subscription-driven business model.

A new platform, Risk Monitor, automates the tracking of permits, community sentiment, and environmental data to help developers stay ahead of project-killing risks.

Railserve's new YardGUARD™ system is more than a safety upgrade. It's a strategic move to rewire industrial rail with integrated, real-time intelligence.

As Rise Therapeutics advances its oral drug R-2487, it’s not just developing another pill. It’s testing a radical new idea: resetting the immune system.

The Center for AI Safety recruits xAI's Devin Kim and launches a D.C. institute, signaling a strategic pivot to bridge the gap between AI labs and the Pentagon.

As its CEO heads to a top investor conference, Zealand Pharma leverages AI and novel peptides to challenge giants in the multi-billion-dollar obesity market.

Crosslist moves beyond software with a guide for resellers, a strategic play to capture the booming resale market by teaching the trade before selling the tool.

A small startup just raised $4M to solve the biggest problem in tech: making AR glasses affordable. Their secret isn't a new gadget, but a materials science breakthrough.

A new study reveals an 'early warning system' in infant guts, offering a window to combat the atopic march before allergies take hold. Is this the future?